Author: DrugPatentWatch - Page 24 - DrugPatentWatch

Freedom of Information Act Access to an Investigational New Drug Application

This article not subject to U.S. Copyright. Published 2019 by the American Chemical Society. Noel T. Southall Abstract We report […]

I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th

This is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. shamil.gizatullin@gowlingwlg.com Although it has become harder to obtain

Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch

Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at

In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means

This paper was originally published by Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, and Chris

This article was originally published by Mahendra Saini, Nikhita Parihar, Shankar Lal Soni, and Vandana Sharma in the Asian Journal

When drug patents expire, billions of dollars in revenues can disappear overnight as competitors enter the market. Accordingly, many investors